Literature DB >> 29693291

Interventions to improve medication adherence among Chinese patients with hypertension: a systematic review and meta-analysis of randomized controlled trails.

Rixiang Xu1,2, Xuefeng Xie1,2, Shuting Li1,2, Xiaoyu Chen1,2, Sheng Wang1,2, Chengyang Hu3, Xiongwen Lv1,2.   

Abstract

OBJECTIVE: A systematic review and meta-analysis of randomized controlled trials (RCTs) were performed to understand the effectiveness of medication adherence (MA) interventions among Chinese patients with hypertension.
METHODS: A literature search was conducted with three English databases (PubMed, Web of Science and Embase) and three Chinese databases (China National Knowledge Infrastructure, Wanfang and VIP Database for Chinese Technical Periodicals) for the period from 1970 to October 2017. Only both RCTs with a minimum of 10 participants in each intervention group and Chinese patients with hypertension as participants were included. A random-effects model was applied to calculate pooled effect sizes with 95% CI. Subgroup analysis was conducted to identify potential sources of heterogeneity from duration of intervention, type of intervener, methods of intervention and sites of intervention. Funnel plots and Egger's test were used to evaluate for publication bias. KEY
FINDINGS: A total of 48 studies met criteria for the meta-analysis, including 14 568 participants, testing 57 independent comparisons. Overall, the effect size revealed that interventions significantly improved MA (pooled relative risk = 1.59, 95% CI: 1.43 to 1.78; pooled Cohen's d = 1.42, 95% CI: 0.976 to 1.876). Interventions were found to significantly reduce blood pressure (BP) (systolic BP: Cohen's d = -0.85, 95% CI: -1.11 to -0.60 and diastolic BP: Cohen's d = -0.73, 95% CI: -1.00 to -0.46). Longer duration of intervention gave better effectiveness. Physician as interventionist, regular follow-up visits and interventions conducted at a hospital were associated with better effectiveness.
CONCLUSION: Adherence interventions improve MA and reduce uncontrolled BP among Chinese patients with hypertension. In the future, investigators should adopt a skill set to address the problem of poor MA.
© 2018 Royal Pharmaceutical Society.

Entities:  

Keywords:  Chinese; hypertension; medication adherence; meta-analysis

Mesh:

Substances:

Year:  2018        PMID: 29693291     DOI: 10.1111/ijpp.12452

Source DB:  PubMed          Journal:  Int J Pharm Pract        ISSN: 0961-7671


  3 in total

1.  Adherence to antihypertensive medication in Russia: a scoping review of studies on levels, determinants and intervention strategies published between 2000 and 2017.

Authors:  Elena Viktorovna Bochkareva; Ekaterina Kronidovna Butina; Irina Vitalievna Kim; Anna Vasilievna Kontsevaya; Oxana Mikhailovna Drapkina; David Leon; Martin McKee
Journal:  Arch Public Health       Date:  2019-09-25

Review 2.  Effectiveness of Educational Interventions on Adherence to Lifestyle Modifications Among Hypertensive Patients: An Integrative Review.

Authors:  Hon Lon Tam; Eliza Mi Ling Wong; Kin Cheung
Journal:  Int J Environ Res Public Health       Date:  2020-04-07       Impact factor: 3.390

3.  Gender differences and determinants of prevalence, awareness, treatment and control of hypertension among adults in China and Sweden.

Authors:  Ailiana Santosa; Yue Zhang; Lars Weinehall; Genming Zhao; Na Wang; Qi Zhao; Weibing Wang; Nawi Ng
Journal:  BMC Public Health       Date:  2020-11-23       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.